LiveMetric receives FDA 510(k) for watch-like blood pressure monitor
LiveMetric announced it has received FDA 510(k) certification for its watch-like blood pressure monitor, the LiveOne.
The cuffless device uses a sensor array placed on a radial artery to generate a pressure waveform. The waveform is then analyzed by an algorithm to determine systolic and diastolic blood pressure and heart rate. Based on FDA 510(k) databaseLiveOne is intended for use in clinical settings by patients 27 years of age and older with palpable radial pulses.
The Luxembourg-based company says LiveOne monitoring will soon be made available through health systems, insurers and self-insured employers for people with hypertension or other medical conditions. Heart.
Kelly Benning, vice president of LiveMetric, said: “The LiveOne device aims to combat the worldwide hypertensive pandemic by providing patients and providers with meaningful, personalized health information. insight to be able to take action in real-time,” Kelly Benning, LiveMetric vice president, said in a statement.
“With watch-like ease, the LiveOne device will change the way hypertension and cardiovascular disease is managed and treated by providing people with insights into lifestyles, behaviors, and lifestyles.” how medication affects their blood pressure. We’re focused on getting this to the millions of users across the channels of our customer base.”
TREND TO BIGGER
Another company behind a watch-like blood pressure device, Aktiia, has announced that it has get European CE mark in early 2021. Swiss startup landed $17.5 million in Series A funding in November. While it’s not yet commercially available in the US, Aktiia announced in January that it will conduct a study with Brigham and Women’s Hospital in Boston.
Omron Healthcare get FDA license for the first time for the HeartGuide wearable blood pressure monitor in 2018.
Meanwhile, Samsung has incorporated blood pressure monitoring to its Galaxy smartwatches in countries where it is regulatory approved. However Electrocardiogram monitoring FDA approved, blood pressure monitoring not available in the US
Apple is also interested in blood pressure monitoring for its Watch. However, like Bloomberg reported in AprilThis technology may not be ready until 2024 at the earliest.